EMA-FDA parallel scientific advice program has ‘limited’ uptake
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesEuropeHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesEuropeHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsProduct Lifecycle